ArticleJournal of substance abuse treatment2015
Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.
Article in Journal of substance abuse treatment, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.Journal of substance abuse treatment · 2020Pooled it
- Pooled it
- Racial Disparities in Unmet Pain Treatment Preference, Pain Treatment Satisfaction and Subsequent Opioid Misuse: A Secondary Analysis of a National Multisite RCT.Journal of general internal medicine · 2026Trial
- Concurrent Use of Extra-Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine: A Cohort Study of Urban Adults Who Have Injected Drugs.Drug and alcohol review · 2026Article
- "You're Hoping for the Best, but Preparing for the Worst": Discussions of Starting Buprenorphine in the Context of Fentanyl Use with Clinicians and People Who Use Fentanyl.Journal of general internal medicine · 2026Article
- Patient experiences of buprenorphine dispensing from a mobile medical unit.Addiction science & clinical practice · 2024Article
- Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.Journal of substance use and addiction treatment · 2023Article
- Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.Substance use & misuse · 2023Article
- Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.Drug and alcohol dependence reports · 2022Article
- Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder.Journal of substance abuse treatment · 2022Article
- Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.JAMA network open · 2021Article
- Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment.Drug and alcohol dependence · 2021Article
- Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.Journal of substance abuse treatment · 2020Article
- Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?The International journal on drug policy · 2020Article
- "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.The International journal on drug policy · 2019Article
- Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.Drug and alcohol dependence · 2019Article
- Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?Substance abuse · 2019Article
- Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program.Substance abuse · 2018Article
- Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.Journal of substance abuse treatment · 2017Article
- Evidence on Buprenorphine Dose Limits: A Review.Journal of addiction medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
Buprenorphine availability continues to expand as an effective treatment for opioid dependence, but increases in availability have also been accompanied by increases in non-prescribed use of the medication. Utilizing data from a randomized clinical trial, this mixed-method study examines associations between use of non-prescribed buprenorphine and subsequent treatment entry and retention. Quantitative analyses (N = 300 African American buprenorphine patients) found that patients with prior use of non-prescribed buprenorphine had significantly higher odds of remaining in treatment through 6 months than patients who were naïve to the medication upon treatment entry. Qualitative data, collected from a subsample of participants (n = 20), identified three thematic explanations for this phenomenon: 1) perceived effectiveness of the medication; 2) cost of obtaining prescription buprenorphine compared to purchasing non-prescribed medication; and 3) convenience of obtaining the medication via daily-dosing or by prescription compared to non-prescribed buprenorphine. These findings suggest a dynamic relationship between non-prescribed buprenorphine use and treatment that indicates potential directions for future research into positive and negative consequences of buprenorphine diversion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.